Nanodrug Delivery for Neurological Disorders

The treatment of neurodegenerative disorders remains a colossal test because of the restricted access of atoms over the blood brain barrier, particularly vast particles, for example, peptides and proteins. Therefore, at most, a little level of a medication that is directed foundationally will achieve the focal sensory system in its dynamic shape. Noninvasive methodologies, for example, nanostructured protein conveyance transporters and intranasal organization, appear to be the most encouraging procedures for the treatment of endless infections, which require long haul mediations. These methodologies are both target-particular and ready to quickly sidestep the blood-brain barrier by means of polymeric micelles or nanogels.

  • Track 1-1 Neurodegenerative Disorders
  • Track 2-2 Bioimaging of the CNS
  • Track 3-3 Barriers to CNS Drug Delivery
  • Track 4-4 Nanocarriers for CNS Drug Delivery
  • Track 5-5 Polymeric Micelles
  • Track 6-6 Nanogels

Related Conference of Nanotechnology